Danaher Corporation $DHR Shares Sold by Welch & Forbes LLC

Welch & Forbes LLC trimmed its position in shares of Danaher Corporation (NYSE:DHR) by 1.0% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 612,657 shares of the conglomerate’s stock after selling 6,338 shares during the period. Danaher makes up about 1.5% of Welch & Forbes LLC’s holdings, making the stock its 19th largest holding. Welch & Forbes LLC’s holdings in Danaher were worth $116,160,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of DHR. Elevated Capital Advisors LLC purchased a new stake in Danaher during the 4th quarter worth approximately $26,000. Hilton Head Capital Partners LLC purchased a new position in Danaher in the fourth quarter valued at $27,000. JPL Wealth Management LLC acquired a new position in Danaher during the 3rd quarter worth $25,000. Clal Insurance Enterprises Holdings Ltd increased its holdings in Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 53 shares during the period. Finally, WFA of San Diego LLC purchased a new position in shares of Danaher in the 2nd quarter valued at about $26,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

DHR traded up $3.13 on Friday, reaching $199.11. The company had a trading volume of 3,847,629 shares, compared to its average volume of 3,706,558. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a market capitalization of $140.92 billion, a PE ratio of 38.51, a P/E/G ratio of 2.54 and a beta of 0.79. The stock has a 50-day moving average price of $180.59 and a 200-day moving average price of $199.48.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business’s revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.88 earnings per share. As a group, research analysts forecast that Danaher Corporation will post 8.44 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s dividend payout ratio (DPR) is 30.95%.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on DHR shares. Guggenheim reduced their target price on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Weiss Ratings downgraded shares of Danaher from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, June 29th. UBS Group cut their price target on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Finally, TD Cowen lowered their price objective on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $231.64.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.